349 related articles for article (PubMed ID: 34419602)
1. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Abuhassan Q; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2021 Nov; 168():90-96. PubMed ID: 34419602
[TBL] [Abstract][Full Text] [Related]
2. Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid.
Inês Silva M; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2022 Aug; 177():126-134. PubMed ID: 35718078
[TBL] [Abstract][Full Text] [Related]
3. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jul; 176():108-121. PubMed ID: 35605926
[TBL] [Abstract][Full Text] [Related]
4. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
5. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
Perrier J; Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert G
Eur J Pharm Sci; 2018 Jan; 111():247-256. PubMed ID: 28987539
[TBL] [Abstract][Full Text] [Related]
6. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
[TBL] [Abstract][Full Text] [Related]
7. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jan; 170():160-169. PubMed ID: 34923138
[TBL] [Abstract][Full Text] [Related]
8. Structured solubility behaviour in fed simulated intestinal fluids.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
[TBL] [Abstract][Full Text] [Related]
9. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
10. Multidimensional analysis of human intestinal fluid composition.
Pyper K; Brouwers J; Augustijns P; Khadra I; Dunn C; Wilson CG; Halbert GW
Eur J Pharm Biopharm; 2020 Aug; 153():226-240. PubMed ID: 32585351
[TBL] [Abstract][Full Text] [Related]
11. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments.
Madsen CM; Feng KI; Leithead A; Canfield N; Jørgensen SA; Müllertz A; Rades T
Eur J Pharm Sci; 2018 Jan; 111():311-319. PubMed ID: 28986196
[TBL] [Abstract][Full Text] [Related]
12. A novel simulated media system for in vitro evaluation of bioequivalent intestinal drug solubility.
Abuhassan Q; Silva MI; Tamimi RA; Khadra I; Batchelor HK; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2024 Jun; 199():114302. PubMed ID: 38657741
[TBL] [Abstract][Full Text] [Related]
13. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
Ainousah BE; Perrier J; Dunn C; Khadra I; Wilson CG; Halbert G
Mol Pharm; 2017 Dec; 14(12):4170-4180. PubMed ID: 29072917
[TBL] [Abstract][Full Text] [Related]
14. Fed intestinal solubility limits and distributions applied to the Developability classification system.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 May; 186():74-84. PubMed ID: 36934829
[TBL] [Abstract][Full Text] [Related]
15. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
16. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
[TBL] [Abstract][Full Text] [Related]
17. Excipient Impact on Fenofibrate Equilibrium Solubility in Fasted and Fed Simulated Intestinal Fluids Assessed Using a Design of Experiment Protocol.
Ainousah BE; Khadra I; Halbert GW
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896244
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Impact of Intestinal Fluid Components on the Solubility and Supersaturation of Danazol.
Madsen CM; Plum J; Hens B; Augustijns P; Müllertz A; Rades T
J Pharm Sci; 2021 Jun; 110(6):2479-2488. PubMed ID: 33428916
[TBL] [Abstract][Full Text] [Related]
19. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs.
Prasad D; Gu CH; Kuldipkumar A
Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029
[TBL] [Abstract][Full Text] [Related]
20. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
